Michael Coston
Editor, Senior Moderator
CDC COCA Call Today: 2025 – 2026 Clinical Recommendations for Seasonal Influenza Prevention and Control
CDC FluView Week 48
#18,980
With a `drifted' H3N2 (subclade K) virus now sweeping the world - and robust, early flu epidemics declared in multiple countries - the CDC will be holding their first COCA (Clinicians Outreach and Communications Activity) call since last September.
Unlike in the past, when viewers (or listeners) could call in to specific phone numbers, or watch online, this webinar will be conducted via Microsoft Teams.
While not spelled out on the webpage, an email from the CDC yesterday stated:
The email also states:
If you are unable to attend the live session of this COCA Call, the closed-captioned video and transcript will be available on the COCA Call webpage approximately one week after the live session.
The slide set will be available on the day of the call on the COCA Call webpage under Webinar.
Free Continuing Education (CE) will be offered for this COCA Call.
Registration is not required.
Although these presentations are often technical, and are of greatest interest to clinicians and healthcare providers, they may also be of interest to the general public.
Details on today's event follow:
2025 – 2026 Clinical Recommendations for Seasonal Influenza Prevention and Control
Health Care Providers
Dec. 11, 2025
At a glance
During this COCA Call, presenters will provide an overview of the burden of influenza disease and discuss recommendations for influenza vaccination, testing, and treatment for people of all ages for the 2025-2026 season.
Overview
Influenza causes a significant burden on the health of Americans during most influenza seasons and remains a serious threat due to its potential to cause severe illness and death. Annual influenza vaccination for people aged 6 months and older is an important way to reduce the risk of influenza and its potentially serious complications that can result in hospitalization and death. Testing for influenza virus infection can guide clinical management, including appropriate antiviral treatment, which is particularly important for people at higher risk for progression to severe disease from influenza—regardless of influenza vaccination status. During this COCA Call, presenters will provide an overview of the burden of influenza disease and discuss recommendations for influenza vaccination, testing, and treatment for people of all ages for the 2025-2026 season.
Webinar
Thursday, December 11, 2025
2:00 – 3:00 PM ET
A few minutes before the webinar begins, please click this link to join.
Presenters
Tim Uyeki, MD, MPH, MPP
Chief Medical Officer
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Lisa A. Grohskopf, MD, MPH
Medical Officer
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Call Objectives
COCA Call Objectives
At the conclusion of the session, the participant will be able to accomplish the following:
,
https://afludiary.blogspot.com/2025/12/cdc-coca-call-today-2025-2026-clinical.html
CDC FluView Week 48
#18,980
With a `drifted' H3N2 (subclade K) virus now sweeping the world - and robust, early flu epidemics declared in multiple countries - the CDC will be holding their first COCA (Clinicians Outreach and Communications Activity) call since last September.
Unlike in the past, when viewers (or listeners) could call in to specific phone numbers, or watch online, this webinar will be conducted via Microsoft Teams.
While not spelled out on the webpage, an email from the CDC yesterday stated:
The email also states:
If you are unable to attend the live session of this COCA Call, the closed-captioned video and transcript will be available on the COCA Call webpage approximately one week after the live session.
The slide set will be available on the day of the call on the COCA Call webpage under Webinar.
Free Continuing Education (CE) will be offered for this COCA Call.
Registration is not required.
Although these presentations are often technical, and are of greatest interest to clinicians and healthcare providers, they may also be of interest to the general public.
Details on today's event follow:
2025 – 2026 Clinical Recommendations for Seasonal Influenza Prevention and Control
Health Care Providers
Dec. 11, 2025
At a glance
During this COCA Call, presenters will provide an overview of the burden of influenza disease and discuss recommendations for influenza vaccination, testing, and treatment for people of all ages for the 2025-2026 season.
Overview
Influenza causes a significant burden on the health of Americans during most influenza seasons and remains a serious threat due to its potential to cause severe illness and death. Annual influenza vaccination for people aged 6 months and older is an important way to reduce the risk of influenza and its potentially serious complications that can result in hospitalization and death. Testing for influenza virus infection can guide clinical management, including appropriate antiviral treatment, which is particularly important for people at higher risk for progression to severe disease from influenza—regardless of influenza vaccination status. During this COCA Call, presenters will provide an overview of the burden of influenza disease and discuss recommendations for influenza vaccination, testing, and treatment for people of all ages for the 2025-2026 season.
Webinar
Thursday, December 11, 2025
2:00 – 3:00 PM ET
A few minutes before the webinar begins, please click this link to join.
Presenters
Tim Uyeki, MD, MPH, MPP
Chief Medical Officer
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Lisa A. Grohskopf, MD, MPH
Medical Officer
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Call Objectives
COCA Call Objectives
At the conclusion of the session, the participant will be able to accomplish the following:
- Cite background information on the topic covered during the presentation.
- Discuss CDC's role in the topic covered during the presentation.
- Describe the topic's implications for clinicians.
- Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
- Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, populations at higher risk, and other members of an interprofessional team of healthcare providers.
- Highlight key recommendations in the CDC Advisory Committee on Immunization Practices' document, "Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2025–26 Influenza Season."
- Describe influenza testing recommendations in outpatients and in hospitalized patients with suspected influenza.
- Review antiviral medications for influenza and CDC's recommendations for antiviral treatment of patients with suspected or lab-confirmed influenza.
- Influenza (Flu) Information for Health Care Providers | Influenza (Flu) | CDC
- ACIP Recommendations Summary | Influenza (Flu) | CDC
- Clinical Guidance for Influenza Vaccination | Influenza (Flu) | CDC
- Overview of Influenza Testing Methods | Influenza (Flu) | CDC
- About Influenza Antiviral Medications | Influenza (Flu) | CDC
,
https://afludiary.blogspot.com/2025/12/cdc-coca-call-today-2025-2026-clinical.html